About 6 results found for searched term "50-53-3" (0.055 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M3628 | RG7112 | Mdm2 |
| RO5045337 | ||
| RG7112 (RO5045337) is the first-in-class small-molecule MDM2 inhibitor designed to occupy the p53-binding pocket of MDM2. | ||
| M6214 | 6-Maleimidocaproic Acid | PROTAC Linker |
| A sulfhydryl reactive heterobifunctional crosslinking reagent. Widely used probe for introducing maleimides groups into biomolecules. A probe for thiol groups in proteins. | ||
| M18699 | Graveobioside A | Others |
| Graveobioside A | ||
| M20535 | Chlorpromazine | Dopamine Receptor |
| Chlorpromazine is an orally active, blood-brain barrier-transparent D2 dopamine receptors and 5-HT2A antagonist. Chlorpromazine also blocks hNav1.7 channels (IC50=25.9 μM; concentration-dependent) and HERG potassium channels (IC50=21.6 μM). | ||
| M24777 | Fremanezumab | CGRP Receptor |
| TEV-48125 | ||
| Fremanezumab (TEV-48125) is a humanized IgG2a monoclonal antibody that selectively and potently binds to calcitonin gene-related peptide (CGRP). CGRP is a 37-amino acid neuropeptide involved in central and peripheral pathophysiological events of migraine. Fremanezumab has the potential for chronic migraine research. | ||
| M30189 | NSC61610 | IL Receptor/Related |
| NSC61610 disrupts hIL-18 binding to the ectromelia virus IL-18BP. NSC61610 inhibits hIL-18:ectvIL-18BP complex formation with an IC50 about 6 uM. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
